Researchers have identified a novel mechanism by which cells die in Alzheimer’s disease, which my aid future therapies targeting cell loss in the brain.
Browsing: Cognitive/neurodegenerative disorders
Three-dimensional structural images of the AMPA receptor have been captured for the first time, offering researchers possible new insights into the exact role of this receptor during excitatory neurotransmission.
In a new case series of 177 players, diagnosis rate is highest recorded to-date.
Megan Zuelsdorff discusses her research into the impact of lifetime stressful experiences on cognition as part of the Wisconsin Registry for Alzheimer’s Prevention Study.
In a podcast recorded live at AAIC in London, Kim Mueller talks about her group’s novel study; the largest prospective, longitudinal study of spontaneous speech samples in a study group of its kind.
A collection of news highlights from AAIC held in London, UK, 16–20 July 2017.
The Lancet International Commission on Dementia Prevention, Intervention and Care has reported that more than one-third of global dementia cases may be preventable through addressing lifestyle factors that impact an individual’s risk.
US POINTER trial aims to examine lifestyle interventions to prevent cognitive decline and dementia in the USA.
The analysis also reported an increase in Alzheimer’s drugs in development from 2016 to 2017.
While at AAIC 2017 in London, Lauren Pulling (Editor, NC) spoke to Julie Williams about her extensive work in Alzheimer’s genetics and risk factors.